Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Plus Therapeutics (PSTV) Return on Capital Employed (2016 - 2025)

Plus Therapeutics (PSTV) has disclosed Return on Capital Employed for 15 consecutive years, with 2.95% as the latest value for Q4 2025.

  • Quarterly Return on Capital Employed fell 463.0% to 2.95% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 2.95% through Dec 2025, down 463.0% year-over-year, with the annual reading at 18.32% for FY2025, 1607.0% up from the prior year.
  • Return on Capital Employed for Q4 2025 was 2.95% at Plus Therapeutics, up from 15.05% in the prior quarter.
  • The five-year high for Return on Capital Employed was 12.29% in Q1 2025, with the low at 15.05% in Q3 2025.
  • Average Return on Capital Employed over 5 years is 1.22%, with a median of 1.19% recorded in 2022.
  • The sharpest move saw Return on Capital Employed skyrocketed 997bps in 2024, then plummeted -1991bps in 2025.
  • Over 5 years, Return on Capital Employed stood at 0.9% in 2021, then plummeted by -89bps to 1.69% in 2022, then plummeted by -390bps to 8.29% in 2023, then surged by 120bps to 1.68% in 2024, then crashed by -276bps to 2.95% in 2025.
  • According to Business Quant data, Return on Capital Employed over the past three periods came in at 2.95%, 15.05%, and 3.29% for Q4 2025, Q3 2025, and Q2 2025 respectively.